A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease

Yong Kyoung Yoo, Jinsik Kim, Gangeun Kim, YoungSoo Kim, Hye Yun Kim, Sejin Lee, Won Woo Cho, Seongsoo Kim, Sang Myung Lee, Byung Chul Lee, Jeong Hoon Lee, Kyo Seon Hwang

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We developed an interdigitated microelectrode (IME) sensor system for blood-based Alzheimer's disease (AD) diagnosis based on impedimetric detection of amyloid-β (Aβ) protein, which is a representative candidate biomarker for AD. The IME sensing device was fabricated using a surface micromachining process. For highly sensitive detection of several tens to hundreds of picogram/mL of Aβ in blood, medium change from plasma to PBS buffer was utilized with signal cancellation and amplification processing (SCAP) system. The system demonstrated approximately 100-folds higher sensitivity according to the concentrations. A robust antibody-immobilization process was used for stability during medium change. Selectivity of the reaction due to the affinity of Aβ to the antibody and the sensitivity according to the concentration of Aβ were also demonstrated. Considering these basic characteristics of the IME sensor system, the medium change was optimized in relation to the absolute value of impedance change and differentiated impedance changes for real plasma based Aβ detection. Finally, the detection of Aβ levels in transgenic and wild-type mouse plasma samples was accomplished with the designed sensor system and the medium-changing method. The results confirmed the potential of this system to discriminate between patients and healthy controls, which would enable blood-based AD diagnosis.

Original languageEnglish
Article number8882
JournalScientific reports
Volume7
Issue number1
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Microelectrodes
Amyloid
Blood
Plasmas
Sensors
Serum Amyloid A Protein
Surface micromachining
Antibodies
Biomarkers
Amplification
Buffers
Processing

All Science Journal Classification (ASJC) codes

  • General

Cite this

Yoo, Yong Kyoung ; Kim, Jinsik ; Kim, Gangeun ; Kim, YoungSoo ; Kim, Hye Yun ; Lee, Sejin ; Cho, Won Woo ; Kim, Seongsoo ; Lee, Sang Myung ; Lee, Byung Chul ; Lee, Jeong Hoon ; Hwang, Kyo Seon. / A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease. In: Scientific reports. 2017 ; Vol. 7, No. 1.
@article{0e9c5ea98e5c4ae2b7fd695a4e7a520e,
title = "A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease",
abstract = "We developed an interdigitated microelectrode (IME) sensor system for blood-based Alzheimer's disease (AD) diagnosis based on impedimetric detection of amyloid-β (Aβ) protein, which is a representative candidate biomarker for AD. The IME sensing device was fabricated using a surface micromachining process. For highly sensitive detection of several tens to hundreds of picogram/mL of Aβ in blood, medium change from plasma to PBS buffer was utilized with signal cancellation and amplification processing (SCAP) system. The system demonstrated approximately 100-folds higher sensitivity according to the concentrations. A robust antibody-immobilization process was used for stability during medium change. Selectivity of the reaction due to the affinity of Aβ to the antibody and the sensitivity according to the concentration of Aβ were also demonstrated. Considering these basic characteristics of the IME sensor system, the medium change was optimized in relation to the absolute value of impedance change and differentiated impedance changes for real plasma based Aβ detection. Finally, the detection of Aβ levels in transgenic and wild-type mouse plasma samples was accomplished with the designed sensor system and the medium-changing method. The results confirmed the potential of this system to discriminate between patients and healthy controls, which would enable blood-based AD diagnosis.",
author = "Yoo, {Yong Kyoung} and Jinsik Kim and Gangeun Kim and YoungSoo Kim and Kim, {Hye Yun} and Sejin Lee and Cho, {Won Woo} and Seongsoo Kim and Lee, {Sang Myung} and Lee, {Byung Chul} and Lee, {Jeong Hoon} and Hwang, {Kyo Seon}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-09370-3",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease. / Yoo, Yong Kyoung; Kim, Jinsik; Kim, Gangeun; Kim, YoungSoo; Kim, Hye Yun; Lee, Sejin; Cho, Won Woo; Kim, Seongsoo; Lee, Sang Myung; Lee, Byung Chul; Lee, Jeong Hoon; Hwang, Kyo Seon.

In: Scientific reports, Vol. 7, No. 1, 8882, 01.12.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A highly sensitive plasma-based amyloid-β detection system through medium-changing and noise cancellation system for early diagnosis of the Alzheimer's disease

AU - Yoo, Yong Kyoung

AU - Kim, Jinsik

AU - Kim, Gangeun

AU - Kim, YoungSoo

AU - Kim, Hye Yun

AU - Lee, Sejin

AU - Cho, Won Woo

AU - Kim, Seongsoo

AU - Lee, Sang Myung

AU - Lee, Byung Chul

AU - Lee, Jeong Hoon

AU - Hwang, Kyo Seon

PY - 2017/12/1

Y1 - 2017/12/1

N2 - We developed an interdigitated microelectrode (IME) sensor system for blood-based Alzheimer's disease (AD) diagnosis based on impedimetric detection of amyloid-β (Aβ) protein, which is a representative candidate biomarker for AD. The IME sensing device was fabricated using a surface micromachining process. For highly sensitive detection of several tens to hundreds of picogram/mL of Aβ in blood, medium change from plasma to PBS buffer was utilized with signal cancellation and amplification processing (SCAP) system. The system demonstrated approximately 100-folds higher sensitivity according to the concentrations. A robust antibody-immobilization process was used for stability during medium change. Selectivity of the reaction due to the affinity of Aβ to the antibody and the sensitivity according to the concentration of Aβ were also demonstrated. Considering these basic characteristics of the IME sensor system, the medium change was optimized in relation to the absolute value of impedance change and differentiated impedance changes for real plasma based Aβ detection. Finally, the detection of Aβ levels in transgenic and wild-type mouse plasma samples was accomplished with the designed sensor system and the medium-changing method. The results confirmed the potential of this system to discriminate between patients and healthy controls, which would enable blood-based AD diagnosis.

AB - We developed an interdigitated microelectrode (IME) sensor system for blood-based Alzheimer's disease (AD) diagnosis based on impedimetric detection of amyloid-β (Aβ) protein, which is a representative candidate biomarker for AD. The IME sensing device was fabricated using a surface micromachining process. For highly sensitive detection of several tens to hundreds of picogram/mL of Aβ in blood, medium change from plasma to PBS buffer was utilized with signal cancellation and amplification processing (SCAP) system. The system demonstrated approximately 100-folds higher sensitivity according to the concentrations. A robust antibody-immobilization process was used for stability during medium change. Selectivity of the reaction due to the affinity of Aβ to the antibody and the sensitivity according to the concentration of Aβ were also demonstrated. Considering these basic characteristics of the IME sensor system, the medium change was optimized in relation to the absolute value of impedance change and differentiated impedance changes for real plasma based Aβ detection. Finally, the detection of Aβ levels in transgenic and wild-type mouse plasma samples was accomplished with the designed sensor system and the medium-changing method. The results confirmed the potential of this system to discriminate between patients and healthy controls, which would enable blood-based AD diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=85029444114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029444114&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-09370-3

DO - 10.1038/s41598-017-09370-3

M3 - Article

C2 - 28827785

AN - SCOPUS:85029444114

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 8882

ER -